Health product recall

TARO-Bupropion XL (2021-09-13)

Starting date:
September 13, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-76475

Last updated: 2021-09-21

Summary

  • Product: TARO-Bupropion XL

Reason

Affected lot may contain black powder in the bottle from charcoal in the desiccant canister.

Depth of distribution

Wholesalers, Retailers.

Affected products

TARO-Bupropion XL

DIN, NPN, DIN-HIM

DIN 02475812

Dosage form

Tablet 

Strength

Bupropion Hydrochloride 300 mg

Lot or serial number

AB88254

Companies

Recalling Firm
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: